These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3374659)

  • 21. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications].
    Lamy B; Morel P; Hervé P
    Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and natural history of alloimmunization following HLA-matched leukocyte transfusion in Hunter's syndrome.
    Kakaiya RK; Greenstein R; Pisciotto PT; Slocum SK; Rosen D; Cable RG; Morse EE
    Ann Clin Lab Sci; 1984; 14(4):276-84. PubMed ID: 6431893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human leucocyte antigen (HLA) system.
    Turner D
    Vox Sang; 2004 Jul; 87 Suppl1():87-90. PubMed ID: 15200613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems and solutions with filtration leukapheresis.
    Djerassi I; Kim JS
    Prog Clin Biol Res; 1977; 13():305-13. PubMed ID: 16277
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases.
    Yang X; Ahmed S; Chandrasekaran V
    Am J Clin Pathol; 2004 Apr; 121(4):590-2. PubMed ID: 15080312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion-associated immune modulation: a reason to TRIM platelet transfusions?
    Geiger TL
    Transfusion; 2008 Sep; 48(9):1772-3. PubMed ID: 18811896
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 32. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
    Bux J
    Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mini-review on platelet refractoriness.
    Rebulla P
    Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Supportive therapy for pronounced bone marrow insufficiency with special reference to granulocytopenia].
    Stacher A; Höcker P; Baumgartner G
    Haematol Blood Transfus; 1978; 21():433-40. PubMed ID: 738647
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of patients refractory to platelet transfusion--an evaluation of methods of donor selection.
    Schiffer CA
    Prog Hematol; 1987; 15():91-113. PubMed ID: 3332393
    [No Abstract]   [Full Text] [Related]  

  • 37. [Course: Human body proteins--clinical and diagnostic aspects. HL-A system in man].
    Mizerski J
    Przegl Lek; 1979; 36(2):285-90. PubMed ID: 377422
    [No Abstract]   [Full Text] [Related]  

  • 38. The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.
    Heddle NM; Blajchman MA
    Blood; 1995 Feb; 85(3):603-6. PubMed ID: 7833464
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies.
    Heddle NM
    Transfus Med Rev; 1994 Jan; 8(1):15-28. PubMed ID: 8136604
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platelet transfusion and isologous HLA].
    Amamiya Y; Hisamatsu J; Ito T; Baba M; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1422-8. PubMed ID: 739602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.